HOMOLOGOUS RECOMBINATION REPAIR TESTING PATTERNS AND BARRIERS IN METASTATIC HORMONE-SENSITIVE AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER ACROSS EUROPE: A REAL-WORLD SURVEY

被引：0
|
作者：
Castro, E. [1 ]
Orji, C. [2 ]
Ribbands, A. [3 ]
Butcher, J. [3 ]
Walley, M. [4 ]
Li, W. [5 ]
Ghate, S. [2 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Merck & Co Inc, Rahway, NJ USA
[3] Adelphi Real World, Bollington, Cheshire, England
[4] Adelphi Real World, Macclesfield, Cheshire, England
[5] AstraZeneca Pharmaceut LP, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD8
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [31] Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer
    Gupta, Shilpa
    To, Tu My
    Graf, Ryon
    Kadel, Edward E.
    Reilly, Norelle
    Albarmawi, Husam
    JCO PRECISION ONCOLOGY, 2024, 8
  • [32] Real-world treatment patterns and survival in men with metastatic castration-resistant prostate cancer (mCRPC) who previously progressed from metastatic hormone-sensitive prostate cancer (mHSPC) between 2020 to 2023 in the United States.
    Raval, Amit D.
    Chen, Guifang
    Korn, Matthew J.
    Bernthaler, Andreas
    Constantinovici, Niculae
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [33] Darolutamide in hormone-sensitive and castration-resistant prostate cancer
    Palmieri, Valeria Emma
    Roviello, Giandomenico
    D'Angelo, Alberto
    Casadei, Chiara
    De Giorgi, Ugo
    Giorgione, Roberta
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (05) : 535 - 544
  • [34] The prognostic significance of homologous recombination repair pathway alterations in metastatic hormone-sensitive prostate cancer.
    Shaya, Justin
    Lee, Aaron
    Cabal, Angelo
    Panian, Justine
    Randall, James Michael
    Millard, Frederick E.
    Stewart, Tyler Francis
    Rose, Brent S.
    Parsons, John Kellogg
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [35] Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Mitchell, Aaron P.
    Meza, Akriti Mishra
    Panageas, Katherine S.
    Lipitz-Snyderman, Allison
    Farooki, Azeez
    Morris, Michael J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 126 - 132
  • [36] Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Aaron P. Mitchell
    Akriti Mishra Meza
    Katherine S. Panageas
    Allison Lipitz-Snyderman
    Azeez Farooki
    Michael J. Morris
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 126 - 132
  • [37] Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer
    Mager, Rene
    Savko, Olga
    Boehm, Katharina
    Thomas, Anita
    Dotzauer, Robert
    Borgmann, Hendrik
    Jaeger, Wolfgang
    Thomas, Christian
    Haferkamp, Axel
    Hoefner, Thomas
    Tsaur, Igor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (12) : 999 - 1005
  • [38] Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer
    Wang, Zhipeng
    Liu, Haoyang
    Zhu, Qiyu
    Chen, Junru
    Zhao, Jinge
    Zeng, Hao
    BMC CANCER, 2024, 24 (01)
  • [39] Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients
    Wenzel, Mike
    Siech, Carolin
    Hoeh, Benedikt
    Koll, Florestan
    Humke, Clara
    Tilki, Derya
    Steuber, Thomas
    Graefen, Markus
    Banek, Severine
    Kluth, Luis A.
    Chun, Felix K. H.
    Mandel, Philipp
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 66 : 46 - 54
  • [40] Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study
    LI, Jian-ri
    Wang, Shian-shiang
    Chen, Chuan-shu
    Yang, Cheng-kuang
    Lu, K. E. V. I. N.
    Cheng, Chen-Li
    Hung, Sheng-Chun
    Chen, Shu-Yen
    Hsu, Chiann Yi
    Chiu, Kun-Yuan
    ANTICANCER RESEARCH, 2022, 42 (10) : 4857 - 4866
12345